What is fuzapladib?
Fuzapladib sodium (Panoquell®-CA1) is an immune modulating medication used to manage the signs associated with acute canine pancreatitis. This medication is for use in dogs only.
Fuzapladib sodium is conditionally approved for use by the U.S. Food and Drug Administration (FDA). Before full approval is granted, more information on the safety and efficacy of this medication must be obtained. This drug may not be used in any way other than that indicated on the label while it is conditionally approved. It is not currently available for use in Canada.
How is fuzapladib given?
Your veterinarian will give your pet fuzapladib intravenously (into the vein), by injection in-clinic. Improvement in the signs associated with acute pancreatitis may be seen within 24 hours.
What if a dose is missed?
This medication will be administered by your veterinarian. It is designed to be given once daily for 3 days. If your dog is not hospitalized during that time, follow your veterinarian’s instructions.
Are there any potential side effects?
Fuzapladib may cause the following side effects:
- Regurgitation, vomiting, or nausea
- Trouble breathing and coughing
- Diarrhea
- Appetite loss
- Jaundice (yellowing of the skin or whites of the eyes)
Contact your veterinarian immediately if you notice anything out of the ordinary and ensure all follow-up lab work and exams are completed as directed by your veterinarian.
Drug sensitivities can develop over time, with repeated exposure. Your pet may have no reaction after the first few doses but may develop a sensitivity later. It is important to watch for signs of an allergic reaction over the entire course of treatment.
Other side effects may occur. If you notice anything unusual, contact your veterinarian immediately. This short-acting medication should stop working within 24 hours, although effects can be longer in pets with liver or kidney disease.
Are there any risk factors for this medication?
DO NOT USE in:
- Dogs that are allergic or sensitive to it
- Dogs that are less than 6 months old
- Dogs that are breeding, pregnant, or nursing
- Dogs that are on non-steroidal anti-inflammatory medications (NSAIDs) such as meloxicam or robenacoxib
- Dogs with pre-existing diseases such as heart disease, liver failure, or kidney disease
Are there any drug interactions I should be aware of?
There are no documented drug interactions for this medication at this time. However, fuzapladib has the potential to increase the blood levels of other medications. Be sure to tell your veterinarian about any medications (including vitamins, supplements, or herbal therapies) that your pet is taking before starting any treatment. .
Although not specifically evaluated during the safety study for this medication, the following medications were used simultaneously with no apparent adverse effects: pain medications (excluding NSAIDs), anti-vomiting medications, antiparasitic medications, vaccinations, and medications used to treat well-controlled preexisting conditions.
Is any monitoring needed with this medication?
- Before starting fuzapladib, your veterinarian may run blood and urine tests to make a diagnosis of pancreatitis.
- Follow your veterinarian’s recommendations for any follow-up testing and recheck examinations.
- If your dog is being treated at home, monitor their appetite and activity levels closely and watch for any of the adverse effects described above. Report any concerns or changes to your veterinarian.
How do I store fuzapladib?
This medication is only licensed for use by a veterinarian, so it will be stored at the veterinary clinic.
What should I do in case of an emergency?
If you suspect an overdose or an adverse reaction to the medication, call your veterinary office immediately. If they are not available, follow their directions in contacting an emergency facility. Be prepared to provide information about the product and your pet's weight and symptoms.
